Abstract Details

Title The Mammalian Target of Rapamycin (mTOR) Signaling Pathway Mediates Epileptogenesis in the Kainate Model of Temporal Lobe Epilepsy

Topic Epilepsy

Presentation(s) (-)

Poster/Presentation
Number 060

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Nargiza Chekeeva	Nargiza Chekeeva has nothing to disclose.
	No disclosure on file
Michael Wong, MD, PhD (Washington Univ-Dept of Neurology)	No disclosure on file
Nikolaos Evangelou, PhD (Nottingham University, QMC campus)	Dr. Evangelou has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Evangelou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UK crown prosecution service. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis .

�鶹��ýӳ��